Fresenius SE & Co. (OTCMKTS:FSNUY) Sets New 12-Month Low – Should You Sell?

Posted by ABMN Staff on May 23rd, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report)’s share price reached a new 52-week low during mid-day trading on Saturday . The stock traded as low as $11.13 and last traded at $11.37, with a volume of 162311 shares traded. The stock had previously closed at $11.84.

Wall Street Analysts Forecast Growth

FSNUY has been the subject of several recent research reports. Morgan Stanley reissued an “overweight” rating on shares of Fresenius SE & Co. in a research report on Monday, April 20th. Citigroup reissued a “buy” rating on shares of Fresenius SE & Co. in a research report on Tuesday, February 3rd. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company has an average rating of “Buy”.

Get Our Latest Report on FSNUY

Fresenius SE & Co. Stock Down 4.0%

The firm has a market capitalization of $25.62 billion, a PE ratio of 15.16 and a beta of 0.68. The firm’s 50 day moving average price is $12.48 and its two-hundred day moving average price is $13.76. The company has a quick ratio of 1.00, a current ratio of 1.32 and a debt-to-equity ratio of 0.47.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last announced its earnings results on Wednesday, May 6th. The company reported $0.24 earnings per share for the quarter, missing the consensus estimate of $0.25 by ($0.01). The firm had revenue of $6.75 billion during the quarter, compared to analysts’ expectations of $6.79 billion. Fresenius SE & Co. had a net margin of 6.55% and a return on equity of 10.29%. As a group, research analysts forecast that Fresenius SE & Co. will post 1.05 EPS for the current fiscal year.

About Fresenius SE & Co.

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.